Could a Pre-Surgery epigenetic boost help fight prostate cancer?
NCT ID NCT06888102
First seen Nov 05, 2025 · Last updated May 12, 2026 · Updated 21 times
Summary
This early-stage study is testing whether giving an epigenetic therapy before prostate removal surgery can make the tumor more visible to the immune system. About 20 men with high-risk prostate cancer will receive the drug before their scheduled prostatectomy. The main goals are to check safety and see if the treatment changes gene activity in the tumor tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-RISK PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cedars-Sinai Cancer at SOCC
RECRUITINGLos Angeles, California, 90048, United States
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.